Recent News for ATXI - Avenue Therapeutics, Inc.

Date Title
May 29 Avenue Therapeutics' Shares March Higher, Can It Continue?
May 29 Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne
May 29 Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders
May 28 Flexion (FLXN) Soars: Stock Adds 6.6% in Session
May 27 Hedge Funds Watching Avenue Therapeutics, Inc. (ATXI) From Afar
May 27 Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?
May 27 Small Drug Industry Prospects Bright Amid Coronavirus Gloom
May 26 Zacks.com featured highlights include: Veritone, Avenue Therapeutics, Turtle Beach, BJ???s Wholesale Club and Atlas Air Worldwide
May 26 Zacks.com featured highlights include: Avenue Therapeutics, Glu Mobile, Yamana Gold and Z Holdings
May 26 How Avenue (ATXI) Stock Stands Out in a Strong Industry
May 22 Pick These 5 Stocks With Superb Relative Price Strength
May 22 4 Breakout Stocks for Impressive Returns
May 11 Avenue Therapeutics EPS beats by $0.09
May 11 Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
Apr 27 Top Ranked Momentum Stocks to Buy for April 27th
Apr 24 The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
Apr 23 Why Avenue Therapeutics (ATXI) Stock Might be a Great Pick
Apr 23 Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
Apr 23 5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
Apr 16 Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's Why
Apr 15 Avenue Therapeutics Update: Shares A Steal Ahead Of Known PDUFA Action Date
Mar 30 Avenue Therapeutics EPS misses by $0.05
Mar 30 Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
Feb 13 Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
Dec 17 Avenue Therapeutics Submits Its NDA; Shares Still Cheap

Back to the Main ATXI Page...